Ledger.Open graph →

SEC Form D · filed May 7, 2015

Theraclone Sciences, Inc

Offering

$4.4M

Sold

$3.1M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SEATTLE, WA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Steven Gillis · Seattle, WAExec · Director Kristine Swiderek · Seattle, WAExec Wende Hutton · San Diego, CADirector Russ Hawkinson · Seattle, WAExec Wendye Robbins · Seattle, WADirector Clifford Stocks · Seattle, WAExec · Director Christopher Mirabelli · Cambridge, MADirector John G. Mauldin · Norcross, GAExec Marc G. Rubin · Norcross, GAExec · Director Gilbert F. Amelio · Norcross, GADirector Steven G. Prelack · Norcross, GAExec · Director Adam A. Forbes · Brooklyn, NYExec · Director Scott A. Estes · Toledo, OHExec · Director Trevor Graham · Raleigh, NCExec · Director Vinod Chopra · Danville, CADirector Julie Corbett · Manteca, CAExec · Director Alexander Brown · Miami, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗